Sonoma Pharmaceuticals Income Statement (2010-2012) | SNOA

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012
Revenue & cost
Revenue 2.26M2.47M2.31M2.71M2.94M3.66M2.79M3.35M4.05M4.53M3.54M
Cost of Revenue 0.88M0.79M1.16M0.78M0.99M0.89M0.94M1.22M1.17M1.33M1.07M
Gross Profit 1.39M1.67M1.15M1.93M1.95M2.78M1.85M2.13M2.88M3.20M2.47M
Operating items
Research & Development 0.40M0.55M0.47M0.63M0.44M0.56M0.51M0.48M0.53M0.51M0.51M
Selling, General & Administrative 3.39M2.77M2.76M2.69M3.53M2.85M3.70M3.12M2.85M3.50M2.64M
Operating Expenses 3.79M3.32M3.23M3.32M3.97M3.41M4.21M3.60M3.38M4.02M3.15M
Operating Income -2.40M-1.65M-2.08M-1.39M-2.02M-0.63M-2.35M-1.47M-0.49M-0.82M-0.68M
EBIT -2.40M-1.65M-2.08M-1.39M-2.02M-0.63M-2.35M-1.47M-0.49M-0.82M-0.68M
Non-operating items
Non Operating Investment Income 0.09M0.17M0.10M0.12M
Interest & Investment Income 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Other Non Operating Income -0.06M0.09M-0.08M
Net income details
EBT -2.46M-1.73M-2.19M-1.54M-2.18M-0.86M-2.61M-1.74M-0.78M-1.10M-0.95M
Profit After Tax -2.38M-1.65M-2.23M-1.69M-2.17M-0.84M-2.55M-1.77M0.45M-1.52M-1.91M
Income from Continuing Operations -2.46M-1.73M-2.19M-1.54M-2.18M-0.86M-2.61M-1.74M-0.78M-1.10M-0.95M
Consolidated Net Income -2.46M-1.73M-2.19M-1.54M-2.18M-0.86M-2.61M-1.74M-0.78M-1.10M-0.95M
Income towards Parent Company -2.46M-1.73M-2.19M-1.54M-2.18M-0.86M-2.61M-1.74M-0.78M-1.10M-0.95M
Preferred Dividend Payments 1.06M
Net Income towards Common Stockholders -2.46M-1.73M-2.19M-1.54M-2.17M-0.86M-2.55M-1.74M-0.62M-1.10M-1.91M
Additional items
EPS (Basic) -0.09-0.06-0.08-0.06-0.08-0.03-0.09-0.06-0.02-0.05-0.05
Shares Outstanding (Weighted Average) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M
EBITDA -2.48M-1.52M-2.25M-1.61M-2.14M-1.01M-2.63M-1.66M0.33M-1.40M-1.93M
Interest Expenses 0.06M0.09M0.11M0.15M0.16M0.23M0.26M0.28M0.29M0.28M0.28M